Evidence map›Paper›PMID 27077852›Full record

ArticleInternational journal of molecular sciences2016

A Novel Role of Serotonin Receptor 2B Agonist as an Anti-Melanogenesis Agent.

Eun Ju Oh, Jong Il Park, Ji Eun Lee, Cheol Hwan Myung, Su Yeon Kim, Sung Eun Chang, Jae Sung Hwang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Computational and structural biotechnology journal · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eun Ju OhDepartment of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University, Yongin 446-701, Korea. singey@naver.com.
Jong Il ParkDepartment of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University, Yongin 446-701, Korea. rystrong@khu.ac.kr.
Ji Eun LeeDepartment of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University, Yongin 446-701, Korea. jieun0405@khu.ac.kr.
Cheol Hwan MyungDepartment of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University, Yongin 446-701, Korea. audjoin2@naver.com.
Su Yeon KimDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong Songpa-gu, Seoul 138-736, Korea. u2u2star@naver.com.
Sung Eun ChangDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong Songpa-gu, Seoul 138-736, Korea. csesnumd@gmail.com.
Jae Sung HwangDepartment of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University, Yongin 446-701, Korea. jshwang@khu.ac.kr.
Kyung Hee University · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BW723C86, a serotonin receptor 2B agonist, has been investigated as a potential therapeutic for various conditions such as anxiety, hyperphagia and hypertension. However, the functional role of BW723C86 against melanogenesis remains unclear. In this study, we investigate the effect of serotonin receptor 2B (5-HTR2B) agonist on melanogenesis and elucidate the mechanism involved. BW723C86 reduced melanin synthesis and intracellular tyrosinase activity in melan-A cells and normal human melanocytes. The expression of melanogenesis-related proteins (tyrosinase, TRP-1 and TRP-2) and microphthalmia-associated transcription factor (MITF) in melan-A cells decreased after BW723C86 treatment. The promoter activity of MITF was also reduced by BW723C86 treatment. The reduced level of MITF was associated with inhibition of protein kinase A (PKA) and cAMP response element-binding protein (CREB) activation by BW723C86 treatment. These results suggest that the serotonin agonist BW723C86 could be a potential therapeutic agent for skin hyperpigmentation disorders.

Indexed as

AnimalsCell LineDown-RegulationHumansIndolesMelaninsMelanocytesMiceProtein-Tyrosine KinasesSerotonin 5-HT2 Receptor AgonistsSignal TransductionThiophenes1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amineIndolesMelaninsProtein-Tyrosine KinasesSerotonin 5-HT2 Receptor AgonistsThiophenesBW723C86CREBmelanogenesisMITFPKA

Identifiers

PMID27077852
PMCPMC4849002
OpenAlexW2337799676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.